Ultragenyx Pharmaceutical Inc.
USD21.78
-1.07 (-4.68%)
CEO
Emil D. Kakkis
IPO Date
2014-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$22.49
Prev. Close
$22.85
Day Low
$21.33
Day High
$22.64
52W Low
$18.29
52W High
$42.37
Market Cap
$2.15B
Volume
1.66M
| 7,751 |
| $0.00 |
| 18 May 2026 | Fust Matthew K | director | A-Award | Acquired | 14,058 | $25.80 |
| 18 May 2026 | SULIMAN SHEHNAAZ | director | A-Award | Acquired | 7,751 | $0.00 |
| 18 May 2026 | SULIMAN SHEHNAAZ | director | S-Sale | Disposed | 5,740 | $25.12 |
| 18 May 2026 | SULIMAN SHEHNAAZ | director | A-Award | Acquired | 14,058 | $25.80 |
| 18 May 2026 | Ray Amrit | director | A-Award | Acquired | 7,751 | $0.00 |
| 18 May 2026 | Ray Amrit | director | A-Award | Acquired | 14,058 | $25.80 |
| 18 May 2026 | Sanders Corazon (Corsee) D. | director | A-Award | Acquired | 7,751 | $0.00 |
| 18 May 2026 | Sanders Corazon (Corsee) D. | director | A-Award | Acquired | 14,058 | $25.80 |
| $1,001 - $15,000 |
| 15 Aug 2025 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 8 Feb 2022 | Ro Khanna | Ro Khanna | Sale | $1,001 - $15,000 |
| 8 Feb 2022 | Ro Khanna | Ro Khanna | Sale | $1,001 - $15,000 |
| 8 Sept 2021 | Kurt Schrader | Kurt Schrader | Purchase | $1,001 - $15,000 |